Browsing Tag
Ephemeral Technologies
1 post
Cerenome eyes 2027 Phase 2 trial as REYOBIQ brain cancer data take center stage
Cerenome is nearing a key REYOBIQ trial update. Explore its Phase 2 plans, CNSY stock outlook and the risks shaping its oncology strategy.